Omada Health Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Revenue	283.3	260.21	169.8	122.78	89.19
Revenue Growth (YoY)	49.36%	53.24%	38.29%	37.67%	-
Cost of Revenue	95.56	89.27	66.92	52.81	46.39
Gross Profit	187.73	170.94	102.88	69.97	42.79
Selling, General & Admin	151.52	142.23	110.61	102.23	88.97
Research & Development	44.57	40.68	35.92	33.74	26.17
Total Operating Expenses	196.09	182.91	146.53	135.97	115.14
Operating Income	-8.36	-11.97	-43.65	-66	-72.35
Interest Income	-4.87	-5.31	-0.81	-5.78	2.2
Interest Expense	-0.71	2.53	4.51	4.71	-4.2
Other Non-Operating Income (Expense)	1.59	3.58	-0.22	2.58	1.83
Total Non-Operating Income (Expense)	-3.99	0.81	3.48	1.51	-0.17
Pretax Income	-6.3	-12.78	-47.14	-67.51	-72.52
Net Income	-6.3	-12.78	-47.14	-67.51	-72.52
Net Income to Common	-6.3	-12.78	-47.14	-67.51	-72.52
Shares Outstanding (Basic)	49	37	8	7	7
Shares Outstanding (Diluted)	51	37	8	7	7
Shares Change (YoY)	540.18%	374.54%	8.88%	1.63%	-
EPS (Basic)	-0.26	-0.35	-6.11	-9.52	-10.39
EPS (Diluted)	-0.27	-0.35	-6.11	-9.52	-10.39
Shares Outstanding	59.24	58.43	8.16	7.39	6.98
Free Cash Flow	21.45	16.93	-34.78	-50.15	-69.7
Free Cash Flow Growth	26.70%	-	-	-	-
Free Cash Flow Per Share	0.42	0.46	-4.50	-7.07	-9.99
Gross Margin	66.27%	65.69%	60.59%	56.99%	47.98%
Operating Margin	-2.95%	-4.60%	-25.71%	-53.75%	-81.12%
Profit Margin	-2.22%	-4.91%	-27.76%	-54.98%	-81.31%
FCF Margin	7.57%	6.51%	-20.48%	-40.85%	-78.15%
EBITDA	-2.69	-6.48	-38.85	-61.55	-68.02
EBITDA Margin	-0.95%	-2.49%	-22.88%	-50.13%	-76.27%
EBIT	-8.36	-11.97	-43.65	-66	-72.35
EBIT Margin	-2.95%	-4.60%	-25.71%	-53.75%	-81.12%

SEC Filings: 10-K · 10-Q